(Q36380191)

13 August 2017

1 reference

title

Controversies in ventricular remodelling (English)

1 reference

13 August 2017

1

Lionel H Opie

1 reference

13 August 2017

3

Bernard J Gersh

1 reference

13 August 2017

2

Patrick J Commerford

1 reference

13 August 2017

Marc A Pfeffer

4

1 reference

PubMed ID

16443044

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

367

1 reference

13 August 2017

9507

1 reference

13 August 2017

356-367

1 reference

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Wall stress and patterns of hypertrophy in the human left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Compensatory hyperfunction of the heart and cardiac insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Mechanotransduction in cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

STRESS signaling pathways that modulate cardiac myocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Stress-activated cytokines and the heart: from adaptation to maladaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The heart in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Stretch-induced programmed myocyte cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Role of oxidative stress in myocardial hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Increased oxidative stress in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Angiotensin-converting enzyme inhibitors: a new mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Effect of sildenafil on cardiac performance in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular relaxation in patients with left ventricular hypertrophy secondary to aortic valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Normalization of diastolic dysfunction in aortic stenosis late after valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Symptomatic aortic stenosis: does systemic hypertension play an additional role?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

gp130 plays a critical role in pressure overload-induced cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Clinical practice. Evaluation and management of chronic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Is it ever too late to operate on the patient with valvular heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Quantitative determinants of the outcome of asymptomatic mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The mitral complex. Interaction of the anatomy, physiology, and pathology of the mitral annulus, mitral valve leaflets, chordae tendineae, and papillary muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

The Mitral Apparatus: Functional Anatomy of Mitral Regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

On the mechanism of functional mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Is mitral regurgitation a viable treatment target in heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Passive epicardial containment prevents ventricular remodeling in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Preservation of cardiac extracellular matrix by passive myocardial restraint: an emerging new therapeutic paradigm in the prevention of adverse remodeling and progressive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Dise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

S100B expression modulates left ventricular remodeling after myocardial infarction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Remodeling in myocardium adjacent to an infarction in the pig left ventricle.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Giant molecule titin and myocardial stiffness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Functional significance of prorenin internalization in the rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Regression of left ventricular hypertrophy: new hope for dying hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac stem cells and mechanisms of myocardial regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

Cardiac cell-repair therapy: clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968074-4

7 January 2021

10.1016/S0140-6736(06)68074-4

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16443044